Viewing Study NCT01489566


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-28 @ 4:49 PM
Study NCT ID: NCT01489566
Status: UNKNOWN
Last Update Posted: 2011-12-14
First Post: 2011-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients
Sponsor: Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module